PTSD

Neurocognitive effects of repeated ketamine infusions in comorbid posttraumatic stress disorder and major depressive disorder

Authors: C Sophia Albott, Kelvin O Lim, Christopher Erbes, Paul Thuras, Joseph Wels, Susanna J Tye, Paulo R Shiroma

Journal: Journal of Affective Disorders

Year Published: 2022

Background: The glutamate N-methyl-d-aspartate (NMDA) receptor antagonist ketamine rapidly ameliorates posttraumatic stress disorder (PTSD) and depression symptoms in individuals with comorbid PTSD and major depressive disorder (MDD). However, concerns over ketamine’s potential neurocognitive side effects have […]

Back to Publications